Please use this identifier to cite or link to this item:
Title: Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
Issue Date: Jan-2017
Citation: Clin Transl Oncol.2017 Jan;(19)1:91-104
Abstract: While much progress has been made in the treatment of breast cancer, cardiac complications resulting from therapy remain a significant concern. Both anthracyclines and novel targeted agents can inflict cardiac damage. The present study aimed to evaluate the difference between what it is currently done and what standards of care should be used to minimizing and managing cardiac toxicity in breast cancer survivors.
PMID: 27101413
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Getafe > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC5215075.pdf707.75 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.